Alcohol-Induced Liver Disease Hospitalizations, Transplants on the Rise
By Elana Gotkine HealthDay Reporter
THURSDAY, Nov. 21, 2024 -- From 2005 to 2021, alcohol-induced liver disease (AILD)-related hospitalizations and liver transplants (LTs) increased among women and men and in younger and older adults, according to a research letter published online Nov. 14 in the Journal of the American Medical Association.
Vrishketan Sethi, M.D., from the University of Pittsburgh Medical Center, and colleagues examined trends in hospitalizations and LTs associated with AILD in the United States from 2005 to 2021. The patient population was stratified into younger and older groups (younger than 40 years and 40 years and older), excluding those younger than 20 years.
The researchers found that per 100,000 individuals, the rates of AILD-related hospitalizations increased from 63.47 to 129.24 in women, from 186.84 to 301.72 in men, from 33.89 to 102.27 among younger patients, and from 177.93 to 273.48 among older patients, respectively, from 2005 to 2021. The greatest relative increases and mean annual percentage change (MAPC) were seen among younger women and younger men (relative increases, 283.21 and 169.07 percent, respectively; MAPCs, 8.93 and 6.34, respectively). Per 1 million people, the rates of AILD-related LT increased from 1.88 to 8.39, from 10.36 to 20.09, from 0.70 to 7.27, and from 9.23 to 17.78 among women, men, younger adults, and older adults, respectively, from 2005 to 2021. The highest relative increases and MAPCs occurred among younger women and younger men (relative increases, 2,283.96 and 683.54 percent, respectively; MAPCs, 19.71 and 14.84, respectively).
"These findings highlight an important need to elucidate the biopsychosocial factors driving alcohol use and formulate preventive strategies targeted to younger individuals, especially females," the authors write.
One author disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-22 06:00
Read more
- AAO: One Year of Valacyclovir Beneficial for Herpes Zoster Ophthalmicus
- Risk for Psychiatric Disorders Up for Offspring of Moms With Eating Disorder
- Metformin Use Tied to Lower Rate of Asthma Attacks
- Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of Selarsdi (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara (ustekinumab)
- Protracted Radiation Exposure Linked to Hematologic Cancer Mortality
- Vasomotor Symptoms During Menopause May Up Risk for Type 2 Diabetes
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions